Table 3.

Comparison of metabolic outcomes in liver transplant recipients randomized to either standard immunosuppression (steroids) or complete avoidance of steroids (no steroids)

	Steroids group (n = 50)	No-steroids group (n = 50)	P-value
Body mass index, kg/m2, mean ± SD
Pre-transplant	29 ± 1	30 ± 1	0.42
6 months post-transplant	27 ± 1	26 ± 1	0.57
1 year post-transplant	28 ± 1	29 ± 1	0.67
Cholesterol, mg/dl, mean ± SD
Pre-transplant	125 ± 6	157 ± 14	0.04
6 months post-transplant	154 ± 8	172 ± 16	0.33
1 year post-transplant	167 ± 11	148 ± 8	0.18
High-density lipoprotein, mg/dl, mean ± SD
Pre-transplant	44 ± 3	44 ± 4	0.95
6 months post-transplant	42 ± 3	40 ± 3	0.69
1 year post-transplant	45 ± 3	45 ± 3	0.99
Low-density lipoprotein, mg/dl, mean ± SD
Pre-transplant	65 ± 4	94 ± 13	0.04
6 months post-transplant	81 ± 7	101 ± 15	0.24
1 year post-transplant	88 ± 11	76 ± 6	0.37
Triglycerides, mg/dl, mean ± SD
Pre-transplant	81 ± 8	97 ± 7	0.14
6 months post-transplant	147 ± 12	148 ± 17	0.96
1 year post-transplant	174 ± 16	142 ± 11	0.10
Creatinine, mg/dl, mean ± SD
Pre-transplant	1.26 ± 0.13	1.31 ± 0.14	0.79
6 months post-transplant	1.24 ± 0.11	1.60 ± 0.14	0.05
1 year post-transplant	1.42 ± 0.16	1.67 ± 0.15	0.24
Anti-hypertensive medications, mean ± SD
Pre-transplant	1.76 ± 0.16	1.70 ± 0.17	0.91
6 months post-transplant	0.61 ± 0.13	0.72 ± 0.14	0.58
1 year post-transplant	0.86 ± 0.15	0.50 ± 0.10	0.05
Insulin-dependent, %
Pre-transplant	18	22	0.62
6 months post-transplant	22	27	0.58
1 year post-transplant	23	27	0.71
Pre-transplant diabetes mellitus, %	24	40	0.09
Post-transplant diabetes mellitus, %	37	43	0.54
On pre-transplant anti-hypertensive, %	74	72	0.82
On post-transplant anti-hypertensive, %	47	55	0.42

SD, standard deviation.